Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma

Nature Communications 7 Article number:12336 (2016); Published 22 August 2016; Updated 29 September 2016

Arthur E. Frankel, who helped to interpret the clinical relevance of the findings, was inadvertently omitted from the authors list during the final stages of production. This has now been corrected in both the PDF and HTML versions of the Article.

Authors

Additional information

The online version of the original article can be found at 10.1038/ncomms12336

Rights and permissions

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Eskiocak, U., Ramesh, V., Gill, J. et al. Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma. Nat Commun 7, 13080 (2016). https://doi.org/10.1038/ncomms13080

Download citation

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.